The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
JC Gutiérrez-Ramos, President and CEO, Synlogic
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
"Trends in automotive robotics," Alexander Zak, Director Corporate R&D, Magna International